Share on StockTwits

Shares of Stemcells (NASDAQ:STEM) were the recipient of a large decline in short interest in July. As of July 31st, there was short interest totalling 4,471,033 shares, a decline of 17.9% from the July 15th total of 5,443,334 shares, Stock Ratings News reports. Based on an average daily trading volume, of 1,310,471 shares, the short-interest ratio is currently 3.4 days. Approximately 7.0% of the company’s stock are sold short.

Several analysts have recently commented on the stock. Analysts at Brinson Patrick initiated coverage on shares of Stemcells in a research note on Wednesday, July 2nd. They set an “outperform” rating and a $7.00 price target on the stock. Separately, analysts at Maxim Group raised their price target on shares of Stemcells from $2.50 to $5.00 in a research note on Friday, June 20th. They now have a “buy” rating on the stock. Finally, analysts at Chardan Capital reiterated a “positive” rating on shares of Stemcells in a research note on Tuesday, June 17th.

Stemcells (NASDAQ:STEM) opened at 1.65 on Wednesday. Stemcells has a 1-year low of $1.15 and a 1-year high of $2.43. The stock has a 50-day moving average of $1.85 and a 200-day moving average of $1.52. The company’s market cap is $91.6 million.

Stemcells (NASDAQ:STEM) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.22) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.14) by $0.08. On average, analysts predict that Stemcells will post $-0.59 earnings per share for the current fiscal year.

StemCells, Inc (NASDAQ:STEM) is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies for academia and industry.

Receive News & Ratings for Stemcells Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stemcells and related companies with Analyst Ratings Network's FREE daily email newsletter.